{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T10:07:07Z","timestamp":1790935627454,"version":"4.1.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2006,3,14]],"date-time":"2006-03-14T00:00:00Z","timestamp":1142294400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Apoptosis"],"published-print":{"date-parts":[[2006,6]]},"DOI":"10.1007\/s10495-006-6314-5","type":"journal-article","created":{"date-parts":[[2006,3,16]],"date-time":"2006-03-16T15:15:06Z","timestamp":1142522106000},"page":"1013-1023","source":"Crossref","is-referenced-by-count":40,"title":["Caspase-independent killing of Burkitt lymphoma cell lines by rituximab"],"prefix":"10.1007","volume":"11","author":[{"given":"I.","family":"Daniels","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. M.","family":"Abulayha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B. J.","family":"Thomson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. P.","family":"Haynes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2006,3,14]]},"reference":[{"key":"6314_CR1","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1023\/A:1011628322057","volume":"12","author":"EM Kirchner","year":"2001","unstructured":"Kirchner EM, Ebsen M, Kirchner J, Theegarten D, Voigtmann R. Transformation of Hodgkin\u2019s disease to high-grade B-cell lymphoma: Remission after Rituximab monotherapy. Ann Oncol 2001; 12: 1169\u20131171.","journal-title":"Ann Oncol"},{"key":"6314_CR2","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1182\/blood.V90.6.2188","volume":"90","author":"DG Maloney","year":"1997","unstructured":"Maloney DG, Grillo-Lopez AJ, White CA, et\u00a0al. IDEC-C2B8 (Rituximab) anti-CD20 monoclonal antibody therapy in patients with relapsed low-grade non-Hodgkin\u2019s lymphoma. Blood 1997; 90: 2188\u20132195.","journal-title":"Blood"},{"key":"6314_CR3","doi-asserted-by":"crossref","first-page":"3521","DOI":"10.4049\/jimmunol.139.10.3521","volume":"139","author":"AY Liu","year":"1987","unstructured":"Liu AY, Robinson RR, Murray ED, Jr., Ledbetter JA, Hellstrom I, Hellstrom KE. Production of a mouse-human chimeric monoclonal antibody to CD20 with potent Fc-dependent biologic activity. J Immunol 1987; 139: 3521\u20133526.","journal-title":"J Immunol"},{"key":"6314_CR4","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1006\/cimm.2000.1693","volume":"204","author":"D Flieger","year":"2000","unstructured":"Flieger D, Renoth S, Beier I, Sauerbruch T, Schmidt-Wolf I. Mechanism of cytotoxicity induced by chimeric mouse human monoclonal antibody IDEC-C2B8 in CD20-expressing lymphoma cell lines. Cell Immunol 2000; 204: 55\u201363.","journal-title":"Cell Immunol"},{"key":"6314_CR5","doi-asserted-by":"crossref","first-page":"3900","DOI":"10.1182\/blood.V95.12.3900","volume":"95","author":"J Golay","year":"2000","unstructured":"Golay J, Zaffaroni L, Vaccari T, et\u00a0al. Biologic response of B lymphoma cells to anti-CD20 monoclonal antibody rituximab in vitro: CD55 and CD59 regulate complement-mediated cell lysis. Blood 2000; 95: 3900\u20133908.","journal-title":"Blood"},{"key":"6314_CR6","doi-asserted-by":"crossref","unstructured":"Cragg MS, Glennie MJ. Antibody specificity controls in vivo effector mechanisms of anti-CD20 reagents. Blood 2003.","DOI":"10.1182\/blood-2003-06-2031"},{"key":"6314_CR7","first-page":"3","volume":"3","author":"O Manches","year":"2002","unstructured":"Manches O, Lui G, Chaperot L, et\u00a0al. In vitro mechanisms of action of rituximab on primary non-Hodgkin\u2019s lymphomas. Blood 2002; 3: 3.","journal-title":"Blood"},{"key":"6314_CR8","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1182\/blood.V91.5.1644","volume":"91","author":"D Shan","year":"1998","unstructured":"Shan D, Ledbetter JA, Press OW. Apoptosis of malignant human B cells by ligation of CD20 with monoclonal antibodies. Blood 1998; 91: 1644\u20131652.","journal-title":"Blood"},{"key":"6314_CR9","doi-asserted-by":"crossref","first-page":"673-83","DOI":"10.1007\/s002620050016","volume":"48","author":"D Shan","year":"2000","unstructured":"Shan D, Ledbetter JA, Press OW. Signaling events involved in anti-CD20-induced apoptosis of malignant human B cells. Cancer Immunol Immunother 2000; 48: 673\u2013683.","journal-title":"Cancer Immunol Immunother"},{"key":"6314_CR10","first-page":"7170","volume":"60","author":"S Mathas","year":"2000","unstructured":"Mathas S, Rickers A, Bommert K, Dorken B, Mapara MY. Anti-CD20- and B-cell receptor-mediated apoptosis: Evidence for shared intracellular signaling pathways. Cancer Res 2000; 60: 7170\u20137176.","journal-title":"Cancer Res"},{"key":"6314_CR11","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1038\/sj.leu.2402559","volume":"16","author":"LE Kolk van der","year":"2002","unstructured":"van der Kolk LE, Evers LM, Omene C, et\u00a0al. CD20-induced B cell death can bypass mitochondria and caspase activation. Leukemia 2002; 16: 1735\u20131744.","journal-title":"Leukemia"},{"key":"6314_CR12","first-page":"5480","volume":"63","author":"HT Chan","year":"2003","unstructured":"Chan HT, Hughes D, French RR, et\u00a0al. CD20-induced lymphoma cell death is independent of both caspases and its redistribution into triton X-100 insoluble membrane rafts. Cancer Res 2003; 63: 5480\u20135489.","journal-title":"Cancer Res"},{"key":"6314_CR13","doi-asserted-by":"crossref","first-page":"2771","DOI":"10.1182\/blood.V98.9.2771","volume":"98","author":"B Bellosillo","year":"2001","unstructured":"Bellosillo B, Villamor N, Lopez-Guillermo A, et\u00a0al. Complement-mediated cell death induced by rituximab in B-cell lymphoproliferative disorders is mediated in vitro by a caspase-independent mechanism involving the generation of reactive oxygen species. Blood 2001; 98: 2771\u20132777.","journal-title":"Blood"},{"key":"6314_CR14","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/S1471-4914(02)02328-6","volume":"8","author":"IS Mathiasen","year":"2002","unstructured":"Mathiasen IS, Jaattela M. Triggering caspase-independent cell death to combat cancer. Trends Mol Med 2002; 8: 212\u2013220.","journal-title":"Trends Mol Med"},{"key":"6314_CR15","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1111\/j.1432-1033.2004.04084.x","volume":"271","author":"C Assuncao Guimaraes","year":"2004","unstructured":"Assuncao Guimaraes C, Linden R. Programmed cell deaths. Apoptosis and alternative deathstyles. Eur J Biochem 2004; 271: 1638\u20131650.","journal-title":"Eur J Biochem"},{"key":"6314_CR16","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1006\/bbrc.2000.3560","volume":"276","author":"J Vier","year":"2000","unstructured":"Vier J, Furmann C, Hacker G. Baculovirus P35 protein does not inhibit caspase-9 in a cell-free system of apoptosis. Biochem Biophys Res Commun 2000; 276: 855\u2013861.","journal-title":"Biochem Biophys Res Commun"},{"key":"6314_CR17","doi-asserted-by":"crossref","first-page":"8359","DOI":"10.1074\/jbc.274.13.8359","volume":"274","author":"HR Stennicke","year":"1999","unstructured":"Stennicke HR, Deveraux QL, Humke EW, Reed JC, Dixit VM, Salvesen GS. Caspase-9 can be activated without proteolytic processing. J Biol Chem 1999; 274: 8359\u20138362.","journal-title":"J Biol Chem"},{"key":"6314_CR18","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0145-2126(98)00013-7","volume":"22","author":"C Pepper","year":"1998","unstructured":"Pepper C, Thomas A, Tucker H, Hoy T, Bentley P. Flow cytometric assessment of three different methods for the measurement of in vitro apoptosis. Leuk Res 1998; 22: 439\u2013444.","journal-title":"Leuk Res"},{"key":"6314_CR19","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0022-1759(00)00178-2","volume":"240","author":"DA Bradbury","year":"2000","unstructured":"Bradbury DA, Simmons TD, Slater KJ, Crouch SP. Measurement of the ADP:ATP ratio in human leukaemic cell lines can be used as an indicator of cell viability, necrosis and apoptosis. J Immunol Methods 2000; 240: 79\u201392.","journal-title":"J Immunol Methods"},{"key":"6314_CR20","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1182\/blood.V98.5.1542","volume":"98","author":"A Renz","year":"2001","unstructured":"Renz A, Berdel WE, Kreuter M, Belka C, Schulze-Osthoff K, Los M. Rapid extracellular release of cytochrome c is specific for apoptosis and marks cell death in vivo. Blood 2001; 98: 1542\u20131548.","journal-title":"Blood"},{"key":"6314_CR21","doi-asserted-by":"crossref","first-page":"31546","DOI":"10.1074\/jbc.M001363200","volume":"275","author":"BW Johnson","year":"2000","unstructured":"Johnson BW, Cepero E, Boise LH. Bcl-xL inhibits cytochrome c release but not mitochondrial depolarization during the activation of multiple death pathways by tumor necrosis factor-alpha. J Biol Chem 2000; 275: 31546\u201331553.","journal-title":"J Biol Chem"},{"key":"6314_CR22","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1083\/jcb.200202130","volume":"158","author":"SP Cregan","year":"2002","unstructured":"Cregan SP, Fortin A, MacLaurin JG, et\u00a0al. Apoptosis-inducing factor is involved in the regulation of caspase-independent neuronal cell death. J Cell Biol 2002; 158: 507\u2013517.","journal-title":"J Cell Biol"},{"key":"6314_CR23","doi-asserted-by":"crossref","first-page":"4727","DOI":"10.1242\/jcs.00210","volume":"115","author":"C Cande","year":"2002","unstructured":"Cande C, Cecconi F, Dessen P, Kroemer G. Apoptosis-inducing factor (AIF): Key to the conserved caspase-independent pathways of cell death? J Cell Sci 2002; 115: 4727\u20134734.","journal-title":"J Cell Sci"},{"key":"6314_CR24","doi-asserted-by":"crossref","first-page":"4561","DOI":"10.1182\/blood-2002-08-2501","volume":"101","author":"G Anether","year":"2003","unstructured":"Anether G, Tinhofer I, Senfter M, Greil R. Tetrocarcin-A\u2013induced ER stress mediates apoptosis in B-CLL cells via a Bcl-2\u2013independent pathway. Blood 2003; 101: 4561\u20134568.","journal-title":"Blood"},{"key":"6314_CR25","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1182\/blood-2003-08-2836","volume":"103","author":"AP Mone","year":"2004","unstructured":"Mone AP, Huang P, Pelicano H, et\u00a0al. Hu1D10 induces apoptosis concurrent with activation of the AKT survival pathway in human chronic lymphocytic leukemia cells. Blood 2004; 103: 1846\u20131854.","journal-title":"Blood"},{"key":"6314_CR26","doi-asserted-by":"crossref","unstructured":"Carew JS, Nawrocki ST, Krupnik YV, et\u00a0al. Targeting endoplasmic reticulum protein transport: A novel strategy to kill malignant B cells and overcome fludarabine resistance in CLL. Blood 2005.","DOI":"10.1182\/blood-2005-05-1923"},{"key":"6314_CR27","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/sj.cdd.4400336","volume":"5","author":"CA Casiano","year":"1998","unstructured":"Casiano CA, Ochs RL, Tan EM. Distinct cleavage products of nuclear proteins in apoptosis and necrosis revealed by autoantibody probes. Cell Death Differ 1998; 5: 183\u2013190.","journal-title":"Cell Death Differ"},{"key":"6314_CR28","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1093\/oxfordjournals.jbchem.a002944","volume":"129","author":"K Miyazaki","year":"2001","unstructured":"Miyazaki K, Yoshida H, Sasaki M, et\u00a0al. Caspase-independent cell death and mitochondrial disruptions observed in the Apaf1-deficient cells. J Biochem 2001; 129: 963\u2013969.","journal-title":"J Biochem"},{"key":"6314_CR29","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1182\/blood.V100.5.1765.h81702001765_1765_1773","volume":"100","author":"AL Rose","year":"2002","unstructured":"Rose AL, Smith BE, Maloney DG. Glucocorticoids and rituximab in vitro: Synergistic direct antiproliferative and apoptotic effects. Blood 2002; 100: 1765\u20131773.","journal-title":"Blood"},{"key":"6314_CR30","doi-asserted-by":"crossref","first-page":"39474","DOI":"10.1074\/jbc.M003370200","volume":"275","author":"TH Kim","year":"2000","unstructured":"Kim TH, Zhao Y, Barber MJ, Kuharsky DK, Yin XM. Bid-induced cytochrome c release is mediated by a pathway independent of mitochondrial permeability transition pore and Bax. J Biol Chem 2000; 275: 39474\u201339481.","journal-title":"J Biol Chem"},{"key":"6314_CR31","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1073\/pnas.97.2.577","volume":"97","author":"S Shimizu","year":"2000","unstructured":"Shimizu S, Tsujimoto Y. Proapoptotic BH3-only Bcl-2 family members induce cytochrome c release, but not mitochondrial membrane potential loss, and do not directly modulate voltage-dependent anion channel activity. Proc Natl Acad Sci USA 2000; 97: 577\u2013582.","journal-title":"Proc Natl Acad Sci USA"},{"key":"6314_CR32","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1038\/sj.leu.2401879","volume":"14","author":"DE Johnson","year":"2000","unstructured":"Johnson DE. Noncaspase proteases in apoptosis. Leukemia 2000; 14: 1695\u2013703.","journal-title":"Leukemia"},{"key":"6314_CR33","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1038\/sj.cdd.4401288","volume":"10","author":"L Egger","year":"2003","unstructured":"Egger L, Schneider J, Rheme C, Tapernoux M, Hacki J, Borner C. Serine proteases mediate apoptosis-like cell death and phagocytosis under caspase-inhibiting conditions. Cell Death Differ 2003; 10: 1188\u20131203.","journal-title":"Cell Death Differ"},{"key":"6314_CR34","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/S0955-0674(02)00383-6","volume":"14","author":"RA Lockshin","year":"2002","unstructured":"Lockshin RA, Zakeri Z. Caspase-independent cell deaths. Curr Opin Cell Biol 2002; 14: 727\u2013733.","journal-title":"Curr Opin Cell Biol"}],"container-title":["Apoptosis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10495-006-6314-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10495-006-6314-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10495-006-6314-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,6]],"date-time":"2023-05-06T19:57:50Z","timestamp":1683403070000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10495-006-6314-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,3,14]]},"references-count":34,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2006,6]]}},"alternative-id":["6314"],"URL":"https:\/\/doi.org\/10.1007\/s10495-006-6314-5","relation":{},"ISSN":["1360-8185","1573-675X"],"issn-type":[{"value":"1360-8185","type":"print"},{"value":"1573-675X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,3,14]]}}}